Emmett V. Glass

Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis

Tony M. Keaveny, David W. Donley, Paul Hoffmann et al. · Journal of Bone and Mineral Research · 2006 · 255 citations

Medicine, Orthopedic Surgery, Bone Augmentation +16

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

Steven Boonen, Fernando Marín, Barbara Obermayer‐Pietsch et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 250 citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled Trial

Chad Deal, M. Omizo, Elliott N. Schwartz et al. · Journal of Bone and Mineral Research · 2005 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

Felicia Cosman, Robert A. Wermers, Christopher Recknor et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 172 citations

Medicine, Pharmacology, Pharmacotherapy +17

Bone Mineral and Collagen Quality in Iliac Crest Biopsies of Patients Given Teriparatide: New Results from the Fracture Prevention Trial

Eleftherios P. Paschalis, Emmett V. Glass, David W. Donley et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 159 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17